CheckRare

Current and Emerging Therapies for Lysosomal Storage Disease

Overview / Abstract:	This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available for other attendees.
Expiration	May 01, 2022
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Webinar / Webcast / Video
Presenters / Authors / Faculty	Ozlem Goker-Alpan, MD, Founder and President, Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) Ari Zimran, MD Founder and Director, Gaucher Unit, Shaare Zedek Medical Center, Jerusalem, Israel
Activity Specialities / Related Topics	Family Medicine, Genetics, Hematology, Internal Medicine, Neurology, Orthopedics, Pediatrics, Primary Care
Sponsors / Supporters / Grant Providers	Takeda Pharmaceuticals USA, Cheisi USA, Ultragenyx Pharmaceutical, and Spark Therapeutics.
Keywords / Search Terms	CheckRare Ozlem Goker-Alpan MD, Ari Zimran MD, gaucher disease, Fabry disease, MPS, Pompe, lysosomal storage disease, rare disease, rare disorder, CheckRare, neurology, hematology, Takeda Pharmaceuticals, Cheisi USA, Ultragenyx Pharmaceutical, Spark Therapeutics. Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map